E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers H > Headlines for Hemcure Inc. > News item
Published on 8/9/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

Hemcure exchanges $1.87 million defaulted note for stock

By Sheri Kasprzak

New York, Aug. 9 - Hemcure Inc. said it has exchanged the full $1,875,100 of the notes it is currently in default under into common shares.

The company issued a total of 218,750 common shares for the notes.

Based in Aurora, Colo., Hemcure is a biotechnology company focused on gastroenterology.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.